Subscribe (Free) to
Daily or Weekly Newsletters
Post a Job

Featured Jobs

Retirement Plan Administrator

Bates & Company, Inc.
(Remote / Winter Park FL)

Bates & Company, Inc. logo

Regional Vice President of Sales

The Retirement Plan Company
(Remote / AL / FL / GA / MS)

The Retirement Plan Company logo

Defined Benefit Combo Cash Balance Compliance Consultant

Loren D. Stark Company (LDSCO)
(Remote)

Loren D.  Stark Company (LDSCO) logo

Director of 3(16) Operations

Compass
(Remote / NH / Hybrid)

Compass logo

Loan & Distribution Specialist

AimPoint Pension
(Remote)

AimPoint Pension logo

Business Development Director

AimPoint Pension
(Remote / Pompano Beach FL / AL / GA)

AimPoint Pension logo

View More Employee Benefits Jobs

Free Newsletters

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Mobile app icon
LinkedIn icon     Twitter icon     Facebook icon

Target Date Funds: A Wonder Drug for Participants or a Pandora's Box for All Concerned (PDF)
Richard D. Glass via Investment Horizons Link to more items from this source
[Opinion]
Mar. 24, 2010
13 pages. Excerpt: The purpose of this paper is to demonstrate why it is in the best interest of 401(k) sponsors, participants, and the fiduciaries themselves for the latter to carefully reexamine their processes for choosing and then monitoring the behavior and use of target date funds (or any other QDIA and/or advice provider). Further, if fiduciaries think it is wise not to do anything until Congress or the DOL takes a course of action, they may be: setting the stage for their participants to incur disastrous outcomes; subjecting themselves and their sponsors to time consuming litigation that could easily run into the millions or tens of millions of dollars.

Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title).
An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above).
© 2024 BenefitsLink.com, Inc.